KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Cash from Investing Activities (2016 - 2026)

West Pharmaceutical Services has reported Cash from Investing Activities over the past 18 years, most recently at -$42.7 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 40.11% to -$42.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$257.3 million through Mar 2026, up 28.41% year-over-year, with the annual reading at -$285.9 million for FY2025, 24.5% up from the prior year.
  • Cash from Investing Activities was -$42.7 million for Q1 2026 at West Pharmaceutical Services, up from -$76.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$42.7 million in Q1 2026 and troughed at -$108.8 million in Q4 2023.
  • The 5-year median for Cash from Investing Activities is -$82.1 million (2023), against an average of -$80.2 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 61.93% in 2023 and later surged 40.11% in 2026.
  • Tracing WST's Cash from Investing Activities over 5 years: stood at -$94.8 million in 2022, then fell by 14.77% to -$108.8 million in 2023, then rose by 3.68% to -$104.8 million in 2024, then increased by 27.39% to -$76.1 million in 2025, then soared by 43.89% to -$42.7 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$42.7 million, -$76.1 million, and -$63.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.